New Product
Commercialization
Focus commercialization pathways on your perfect product-market fit and pinpoint market opportunities with precision.
MORE
Growth
Acceleration
Supercharge your commercial teams with comprehensive, up-to-date market and customer intelligence to rapidly scale market impact.
MORE
Market Segments
Medtech Diagnostics Digital Health Drug Delivery BioPharma
About

S2N Health:
Your Partner in MedTech
Commercial Success

S2N Health: Your Partner in MedTech Commercial Success

Established in 2011, S2N Health propels go-to-market and growth strategies through value-maximizing market and customer intelligence.

We have collaborated with over 180 companies, ranging from startups to global enterprises, delivering tailored analytics and valuable insights that shape pivotal product, commercial, and business decisions. Our approach involves merging deep domain expertise in medtech, diagnostics, digital health, and drug delivery with enhanced market and customer data, unlocking the full potential of our clients’ innovations.

In 2021, S2N Health launched RepSignal—an advanced AI-powered SaaS platform. Deploying leading-edge AI algorithms, RepSignal efficiently consolidates vast amounts of healthcare data and translates them into actionable insights for commercial teams and other stakeholders. RepSignal provides effective end-to-end solutions for any stage in the commercial lifecycle, from pre-launch to M&A. Customers can use RepSignal as stand-alone platform or seamlessly integrated into Salesforce.com, Hubspot, or other CRM or analytics platform.

Meet Our Leadership Team

Amy Siegel
Co-Founder & CEO
Amy's extensive involvement in the medtech industry, both as an executive and consultant, laid the foundation for co-founding S2N Health. Her experience revealed that achieving commercial success relies on more than mere market data—it hinges on extracting applicable intelligence from it. Amy's deep insights into propelling market impact played a pivotal role in shaping the development of RepSignal, an end-to-end SAAS solution for healthcare technology companies.
Tim Kofol
Co-Founder & CTO
Tim is an unparalleled expert in data science, coding, machine learning, and artificial intelligence. Leveraging his extensive industry knowledge in both business and technology, he channels his expertise into software engineering at S2N Health. Tim has spearheaded the distinctive architecture and algorithms that underpin RepSignal's data consolidation and advanced AI-powered analytics, a leading-edge solution at the intersection of healthcare and technology.
Katie Grimm
Vice President of Sales
Katie’s experience and leadership in navigating sophisticated software products and complex sales landscapes have seamlessly integrated her into the S2N Health team. Her commitment to cultivating lasting partnerships underscores her approach to delivering not just solutions but enduring value to clients. Katie's distinctive ability to foster relationships and prioritize long-term collaboration is a defining feature of her impactful contributions to S2N Health.
Charles Paglione
Services Lead
Charles expertise in bioengineering and medical technology puts him at the epicenter of transforming industry data with advanced analytics into actionable insights, guiding pivotal business decisions for our clients.
Kelsey Hirsch
Senior Director of Product
Kelsey has led the development of our RepSignal platform since its inception. Kelsey manages our product life cycles and creates roadmaps to outline the vision and goals for ongoing product development.
Krista Kett
Director of Operations
Krista has been part of S2N Health from the very beginning. Her positivity, resourcefulness, and ability to respond quickly to unique situations and problems has helped grow the company to where we are today.

Advisors

John D’Amore
CEO
More Informatics
Strategic Advisor, Director, and former President & Strategy Officer at Diameter Health.
Bruce Shook
Serial MedTech
Entrepreneur
Former CEO of Neuronetics, serves on several medtech company boards, two exits to Philips.
Dave Roberts
President U.S. Market
Medtronic, retired
39-year commercial leadership career with Medtronic spanning multiple operating units.
Howard Rosen
CEO
Evident Vascular
Former Sales & Marketing Leadership roles at Vesper Medical, Intact Vascular & Boston Scientific.
Matthew Bellows
General Partner
Grit Capital Partners
Former VP Business Development at Amex, Founder of Yesware, Bodeswell, and WGR Media.
Martha Shadan
Advisor & Board Member At
Multiple MedTech Companies
Former CEO of Miach Orthopaedics and Rotation Medical—exit to Smith & Nephew.
Dr. Edward Kerslake
Investor & Board Member
MedTech, IT & Pharma
Management Advisor and Board Member at GI Scientific and Allurion. Former CEO of Topera Medical.